The Role of Genome-Wide Association Study in Pulmonary Disease Diagnostics: A Review in Medical Bioinformatics
Downloads
Biomedical science, which initially required only conventional research in the laboratory, currently involves information technology and has created bioinformatics in its development. Bioinformatics, a branch of biology, quantitatively analyzes information within biological macromolecules using software. Contemporary applications of bioinformatics have advanced biotechnological, medical, and pharmaceutical practices. Among the established applications of bioinformatics is diagnosing lung diseases using the genome-wide association study (GWAS) technique. Owing to sequencing technology and rapid computational methods, this technique is applied to analyze the link between genes with essential traits in the population, thus mapping the target genes to diagnose and treat diseases. The lung diseases diagnosed using GWAS include the responsible locus in asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Moreover, it can identify the treatment for COPD and suggest a new locus in lung cancer. Advancing the current gene-mapping technology demands genotype and phenotype data to study disease-linked genomes. Currently, bioinformatics is barely known and receives little attention in Indonesia. However, it can grow rapidly through open-source basis data and cross-disciplinary collaboration.
Aprilyanto V, Sembiring L. Bioinformatika. 1st ed. Yogyakarta: Innosain, https://opac.perpusnas.go.id/DetailOpac.aspx?id=1155075 (2017).
Ethica SN. Pengantar Bioinformatika untuk Mahasiswa Laboratorium Medis. Sleman: Deepublish, https://opac.perpusnas.go.id/DetailOpac.aspx?id=1279557 (2019).
Tenenbaum JD. Translational Bioinformatics: Past, Present, and Future. Genomics Proteomics Bioinformatics 2016; 14: 31–41. [PubMed]
Allen RJ, Guillen-Guio B, Oldham JM, et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2019; 201: 564–574. [PubMed]
Bossé Y, Amos CI. A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 2018; 27: 363–379. [PubMed]
Moll M, Sakornsakolpat P, Shrine N, et al. Chronic Obstructive Pulmonary Disease and Related Phenotypes: Polygenic Risk Scores in Population-Based and Case-Control Cohorts. Lancet Respir Med 2020; 8: 696–708. [PubMed]
Kim KW, Ober C. Lessons Learned From GWAS of Asthma. Allergy Asthma Immunol Res 2019; 11: 170–187. [PubMed]
Uffelmann E, Huang QQ, Munung NS, et al. Genome-Wide Association Studies. Nat Rev Methods Prim 2021; 1: 59. [Journal]
Health NI of. National Human Genome Research Institute (NHGRI). The NIH Almanac, https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-human-genome-research-institute-nhgri (2023).
Chen X, Sullivan PF. Single Nucleotide Polymorphism Genotyping: Biochemistry, Protocol, Cost and Throughput. Pharmacogenomics J 2003; 3: 77–96. [PubMed]
Skol AD, Scott LJ, Abecasis GR, et al. Joint Analysis is More Efficient than Replication-Based Analysis for Two-Stage Genome-Wide Association Studies. Nat Genet 2006; 38: 209–213. [PubMed]
Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of Linkage and Association Genetic Mapping Studies of Complex Traits. Bioinformatics 2003; 19: 149–150. [PubMed]
Auton A, Abecasis GR, Altshuler DM, et al. A Global Reference for Human Genetic Variation. Nature 2015; 526: 68–74. [PubMed]
Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 Diverse Genomes from the NHLBI TOPMed Program. Nature 2021; 590: 290–299. [Journal]
Spagnolo P, Kropski JA. Genome-Wide Association Studies in Idiopathic Pulmonary Fibrosis: Bridging the Gap between Sequence and Consequence. Am J Respir Crit Care Med 2019; 201: 508–509. [PubMed]
Hall R, Hall IP, Sayers I. Genetic Risk Factors for the Development of Pulmonary Disease Identified by Genome-Wide Association. Respirology 2019; 24: 204–214. [PubMed]
Chang I-S, Jiang SS, Yang JC-H, et al. Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors. Am J Respir Crit Care Med 2017; 195: 663–673. [PubMed]
Li Y, Wang W, Gao R, et al. Genome"‘Wide Prioritization Reveals Novel Gene Signatures associated with Cardiotoxic Effects of Tyrosine Kinase Inhibitors. Oncol Lett 2021; 21: 94. [PubMed]
Xu C, Lei L, Wang W, et al. Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs. Transl Oncol 2020; 13: 100791. [PubMed]
Cano-Gamez E, Trynka G. From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases. Frontiers in Genetics; 11, https://www.frontiersin.org/articles/10.3389/fgene.2020.00424 (2020).
Zhu Z, Li J, Si J, et al. A Large-Scale Genome-Wide Association Analysis of Lung Function in the Chinese Population Identifies Novel Loci and Highlights Shared Genetic Aetiology with Obesity. Eur Respir J; 58. Epub ahead of print October 2021. [PubMed]
Copyright (c) 2024 Rossalyn Andromeda, Irandi Putra Pratomo, Ahmad Fauzi, Tutug Kinasih, Prasenohadi Prasenohadi, Arif Santoso, Kentaro Tokumo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.